Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.7 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.7 |